Compounds > topotecan
Page last updated: 2024-08-24

topotecan and B16 Melanoma

topotecan has been researched along with B16 Melanoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boehm, JC; Caranfa, MJ; Faucette, LF; Gallagher, G; Hecht, SM; Holden, KG; Jakas, DR; Johnson, RK; Kingsbury, WD; McCabe, FL1
Andrade, LM; Brito, LB; Esteves, NLS; Gratieri, T; Lima, EM; Marreto, RN; Oliveira, GAR; Taveira, SF; Valadares, MC; Venâncio, JH1
Banerjee, R; Prasad, C1
de Lange, J; Jager, MJ; Jochemsen, AG; Lodder, K; Ly, LV; Teunisse, AF; Verlaan-de Vries, M1
Ju, RJ; Li, N; Li, RJ; Lu, WL; Wang, XX; Wang, ZH; Yao, HJ; Yu, Y; Zhang, L; Zhang, Y; Zhou, J1

Other Studies

5 other study(ies) available for topotecan and B16 Melanoma

ArticleYear
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:1

    Topics: Animals; Antineoplastic Agents; Camptothecin; Cattle; Cell Line; Colonic Neoplasms; DNA, Superhelical; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Leukemia L1210; Lung Neoplasms; Melanoma, Experimental; Mice; Molecular Structure; Plasmids; Structure-Activity Relationship; Thymus Gland; Topoisomerase I Inhibitors; Transplantation, Heterologous

1991
Topotecan-loaded lipid nanoparticles as a viable tool for the topical treatment of skin cancers.
    The Journal of pharmacy and pharmacology, 2017, Volume: 69, Issue:10

    Topics: Administration, Topical; Animals; Antineoplastic Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Hydrogels; Lipids; Melanoma, Experimental; Mice; Nanoparticles; Organ Culture Techniques; Skin Absorption; Skin Neoplasms; Swine; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome

2017
Ultrasound-Triggered Spatiotemporal Delivery of Topotecan and Curcumin as Combination Therapy for Cancer.
    The Journal of pharmacology and experimental therapeutics, 2019, Volume: 370, Issue:3

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Curcumin; Drug Delivery Systems; Female; Humans; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanostructures; Neoplasms, Experimental; Topotecan; Ultrasonics

2019
Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma.
    Oncogene, 2012, Mar-01, Volume: 31, Issue:9

    Topics: Animals; Antineoplastic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Drug Synergism; Furans; Humans; Hypoxia; Imidazoles; Melanoma; Melanoma, Experimental; Mice; Phosphorylation; Piperazines; Protein Serine-Threonine Kinases; Topotecan; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Uveal Neoplasms

2012
Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanoma.
    Biomaterials, 2012, Volume: 33, Issue:6

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Liposomes; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Skin Neoplasms; Topotecan

2012